{"version":"1.0","type":"link","title":"Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.","author_name":"Kim TM 외","author_url":"https://prs-insight.online/author/Kim%20TM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/93590","thumbnail_width":1200,"thumbnail_height":630}